ribavirin has been researched along with isoproterenol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Johnson, GS; Mukku, VR | 1 |
| Antonicelli, F; Haye, B; Jacquemin, C; Lambert, B | 1 |
| Hizi, A; Reitman, P; Shechter, Y | 1 |
1 review(s) available for ribavirin and isoproterenol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for ribavirin and isoproterenol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Evidence in intact cells for an involvement of GTP in the activation of adenylate cyclase.
Topics: Adenosine Triphosphate; Adenylyl Cyclases; Cell Line; Cholera Toxin; Cyclic AMP; Enzyme Activation; Guanosine Triphosphate; Isoproterenol; Kinetics; Mycophenolic Acid; Prostaglandins E; Ribavirin | 1979 |
Activation of adenylate cyclase in rat fat cells promotes an increase in GTP content which controls the enzyme activity.
Topics: Adenosine Triphosphate; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adipose Tissue; Animals; Cyclic AMP; Enzyme Activation; Guanosine Triphosphate; Isoproterenol; Kinetics; Lipolysis; Pertussis Toxin; Phenylisopropyladenosine; Rats; Ribavirin; Virulence Factors, Bordetella | 1988 |
Evaluation of factors responsible for the inability of insulin to antagonize lipolysis due to high concentrations of catecholamines.
Topics: Adipose Tissue; Animals; Catecholamines; Cyclic AMP; Insulin; Isoproterenol; Linoleic Acid; Linoleic Acids; Lipolysis; Male; Rats; Rats, Inbred Strains; Ribavirin; Sodium Cyanide | 1982 |